<DOC>
	<DOCNO>NCT00763958</DOCNO>
	<brief_summary>This study feasibility acceptability study assess whether provide buprenorphine woman criminal justice supervision leave control environment return community would prevent opioid relapse reduce HIV risk behavior .</brief_summary>
	<brief_title>Relapse Prevention Reduce HIV Among Women Prisoners</brief_title>
	<detailed_description>This study seek enroll opioid dependent woman supervision criminal justice system control environment ( substance abuse treatment ) high risk opioid relapse engage HIV risk behavior return community . Initially , 9 woman enrol received buprenorphine medication . After first 9 participant , woman randomize either buprenorphine placebo . Women receive buprenorphine medication 12 week community end 12 week transition either another buprenorphine provider , methadone provider , taper buprenorphine base participant 's preference . One additional follow-up 3 month treatment conduct . The primary outcome opioid positive urines time point .</detailed_description>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>female , history opioid dependence , release back community control environment , criminal justice involvement . age 19 , medical contraindication , major psychiatric problem .</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>opiate</keyword>
	<keyword>HIV</keyword>
</DOC>